China Universal Asset Management Company’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
KCM
China Universal Asset Management Company's LEGN Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Legend Biotech (LEGN) stake by 10% in Q2 2026, selling an estimated $41.7K and leaving 13,433 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #286.
China Universal Asset Management Company first reported a position in LEGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $858K in Q1 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.
- China Universal Asset Management Company held 13,433 shares of Legend Biotech worth $388K as of Q2 2026.
- China Universal Asset Management Company sold 1,545 Legend Biotech shares in Q2 2026, an estimated $41.7K.
- Legend Biotech made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #286 holding.
- China Universal Asset Management Company first reported a position in Legend Biotech in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Legend Biotech position peaked at $858K in Q1 2024.
- 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.